Pieces of evidence have also shown that dysfunctional DNA repair is a possible factor for bcr-abl fusion genetic mutations, and the IM resistance mechanism has been linked to such mutations in CML to some extent [32]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.